Back to BARCLAYS PLC BARCLAYS PLC

SKYESKYE
8 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in SKYE BIOSCIENCE INC

Yes. Barclays holds 655 shares of SKYE (Skye Bioscience), worth $455, as of its Q2 2026 13F filing. It reduced the position by 17,434 shares (-96.4%) from Q1 2026. Barclays has held SKYE since Q4 2025, across 3 quarterly 13F filings.

Current Value

$455

Current Shares

655

Total Value Change

-$338,673

Total Shares Change

-41,683

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
655
-96.4%
$4550.0%$5.54
0
2026-Q1
Decreased
18,089
-14.9%
$11,1170.0%$4.92
0
2025-Q4
New
21,251
-
$15,9320.0%$6.00
28
2025-Q2
Exited
0
-100.0%
$00.0%$33.44
0
2025-Q1
Decreased
20,006
-71.3%
$31,8100.0%$12.72
0
2024-Q4
Increased
69,620
+20.3%
$197,0240.0%$22.64
27
2024-Q3
Increased
57,889
+36.7%
$226,3460.0%$31.28
30
2024-Q2
New
42,338
-
$339,1280.0%$64.08
33

Other major holders of SKYE: BlackRock Finance, Inc., Janus Henderson Group Ltd., BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used